Cranial burr hole with erythropoietin administration induces reverse arteriogenesis from the enriched extracranium

• Published in: Neurobiology of disease 2019-12, Vol.132, p.104538-104538, Article 104538
• Main Authors: Park, Geun Hwa, Shin, Hee Sun, Choi, Eun Sil, Yoon, Bok Seon, Choi, Mun Hee, Lee, Seong-Joon, Lee, Kyung-Eon, Lee, Jin Soo, Hong, Ji Man
• Format: Article
• Language: English
• Subjects: Angiogenesis; Arteriogenesis; Cranial burr hole; Erythropoietin; Ischemic stroke
• ISSN: 0969-9961; 1095-953X
• DOI: 10.1016/j.nbd.2019.104538

It is challenging to revitalize ischemic penumbra after an acute stroke with intracranial perfusion insufficiency. To evaluate whether cranial burr hole and erythropoietin (EPO) generate effective revascularization, we investigated the efficacy of the augmentation method for reverse arteriogenesis from the healthy extracranial milieu. An intracranial perfusion insufficiency was created through bilateral internal carotid artery ligation (bICAL) in Sprague-Dawley rats. We administered recombinant human EPO (5000 U/kg) or saline intraperitoneally for 3 days after bICAL. Mechanical barrier disruption (MBD) was performed through a cranial burr hole with small dural cracks in the right hemisphere. The ipsilateral hemisphere with MBD grossly showed vascular networks between the extra- and intra-cranial spaces 2 weeks after the MBD procedure. It also showed significantly increased vessels in the intracranial vasculature adjacent to the MBD region (p = 0.0006). The levels of pro-angiogenic and inflammatory factors with prominent markers of vessel permeability were also significantly increased (MBD-only vs. control; Tnf-α, p = 0.0007; Vegf, p = 0.0206). In the EPO-administered group, such elevations in inflammation were significantly mitigated (combined vs. MBD-only; Tnf-α, p = 0.0008). The ipsilateral hemisphere with MBD-EPO (vs. MBD-only) showed significantly increased vessels (RECA-1, p = 0.0182) and their maturation (RECA-1/α-SMA, p = 0.0046), with upregulation of tumor growth factor-β1 (Tgf-β1, p = 0.037) and matrix metalloproteinase-2 (Mmp-2, p = 0.0488). These findings were completely blocked by minocycline (MIC) administration during in vivo (Tgf-β1, p = 0.0009; Mmp-2, p